Simplify Propel Opportunities ETF
Price through Oct 2 · Flows through Oct 1. Figures use the latest available records, not a live quote. Fund details retrieved Oct 2. Holdings snapshot retrieved Oct 2.
The fund is an actively managed exchange-traded fund. The Sub-Adviser concentrates the fund's investments (i.e., invests more than 25% of its net assets) in the securities of issuers in the biotechnology, pharmaceuticals, healthcare technology, and life science tools and services industries. The Sub-Adviser employs an actively managed opportunistic multi-asset strategy that focuses on common stock, preferred stock, convertible bonds, structured notes, corporate notes and bonds, and ETFs that primarily invest in the preceding security types. The fund is non-diversified.
SOURCE: MARKET TAPE & DAILY CREATION/REDEMPTION RECORDS · 6M SHOWN · NET +$1M OVER THIS RANGE
Money keeps arriving — +$740K of net inflows over the past month, about 1.0% of the fund's asset base, while the price has returned +2.3% so far this year. At 2.51% a year it is not the cheapest way in — JDOC has a reported fee of 0.65%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | PAGPPLAINS GP HOLDINGS LP | 44.27% | $26.06 | +0.5% | ||
| 2 | ACHVACHIEVE LIFE SCIENCES | 9.42% | $7.24 | -3.9% | ||
| 3 | DCTHDELCATH SYSTEMS | 4.66% | $15.13 | -1.8% | ||
| 4 | MISTMILESTONE PHARMACEUTICALS | 3.67% | $0.81 | -0.7% | ||
| 5 | CORTCORCEPT THERAPEUTICS | 3.15% | $116.23 | +1.9% | ||
| 6 | COLLCOLLEGIUM PHARMACEUTICAL | 2.74% | $22.02 | +0.8% | ||
| 7 | PHATPHATHOM PHARMACEUTICALS | 2.37% | $6.92 | -2.3% | ||
| 8 | ABEOABEONA THERAPEUTICS | 1.86% | $5.03 | +0.4% | ||
| 9 | OBIOORCHESTRA BIOMED HOLDINGS | 1.87% | $5.95 | -6.3% | ||
| 10 | AQSTAQUESTIVE THERAPEUTICS | 1.66% | $4.55 | +2.5% | ||
| 11 | KYTXKYVERNA THERAPEUTICS INC | 1.60% | $6.22 | -4.6% | ||
| 12 | IVAINVENTIVA SA | 1.46% | $3.56 | +2.9% | ||
| 13 | CABACABALETTA BIO | 1.41% | $2.00 | +5.8% | ||
| 14 | CMPSCOMPASS PATHWAYS | 1.45% | $11.90 | -0.4% | ||
| 15 | PROKPROKIDNEY | 1.11% | $1.72 | +0.6% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus CSV export, watchlists, and flow alerts — unlock across the network.
Sign in to see all 29| 1 week | -2.7% |
| 1 month | -16.4% |
| 3 months | -5.0% |
| 6 months | +9.6% |
| YTD | +2.3% |
| 1 year | +6.5% |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | — |
| 1 month | +$740K |
| 3 months | +$1M |
| YTD | +$1M |
| 1 year | +$1M |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
The top holding is 44.3% of the book; the top ten carry 81%. Spread across 33+ names, it behaves like roughly 5 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
Due diligence cuts both ways. These funds sit on the same shelf and beat SURI on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| SPDW State Street SPDR Portfolio Developed World ex-US ETF | 0.03% | $41.5B | +$286M | -248bp on fee · 549× the assets · +$286M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.2B | +$199M | -248bp on fee · 241× the assets · +$199M in over the month | Head-to-head |
| IDEV iShares Core MSCI International Developed Markets ETF | 0.04% | $32.9B | +$497M | -247bp on fee · 435× the assets · +$497M in over the month | Head-to-head |
| IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF | 0.04% | $23.7B | +$575M | -247bp on fee · 313× the assets · +$575M in over the month | Head-to-head |
| IGIB iShares 5-10 Year Investment Grade Corporate Bond ETF | 0.04% | $18.6B | +$412M | -247bp on fee · 246× the assets · +$412M in over the month | Head-to-head |